Mineralys Therapeutics grants director Lonnel Coats 12,400 restricted stock units
MLYS•Mineralys Therapeutics granted director Lonnel Coats 12,400 common shares and 16,600 stock options with a $20.92 exercise price, expiring Oct. 19, 2036.
1. Equity awards
Mineralys Therapeutics granted director Lonnel Coats 12,400 common shares on Oct. 19, 2026. Coats also received 16,600 stock options with a $20.92 exercise price, expiring Oct. 19, 2036.
